跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,829 条关于
“Antibody Mediated Rejection”
全部
38,829
临床试验
28,444
药物
2,251
机构
69
资讯
8,065
去年
Imlifidase Demonstrates Superior Efficacy Over Plasmapheresis in Kidney Transplant Recipients with Antibody-Mediated Rejection
去年
Biogen Initiates Phase 3 TRANSCEND Trial of Felzartamab for Late Antibody-Mediated Kidney Transplant Rejection
去年
Phase 3 Trial of Clazakizumab Fails to Meet Primary Endpoint in Chronic Active Antibody-Mediated Kidney Transplant Rejection
去年
Biogen's Felzartamab Receives FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
去年
CASI Pharmaceuticals Surges 57% Following FDA Clearance for CID-103 Kidney Transplant Rejection Therapy
11个月前
CareDx's SHORE Study Validates AlloSure Heart as Reliable Biomarker for Heart Transplant Rejection
上个月
Biogen Extends Felzartamab Kidney Transplant Rejection Trial Into Four-Year Long-Term Safety Study
去年
Phase 3 IMAGINE Trial of Clazakizumab in Kidney Transplant Rejection Fails to Meet Primary Endpoint
去年
Blood Test Shows Promise for Early Detection of Heart Transplant Rejection, Could Replace 80% of Invasive Biopsies
去年
CASI Pharmaceuticals to Host Conference Call on May 21 to Provide Business and Clinical Updates
第 1 页，共 807 页
上一页
下一页
